Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| effector memory CD8-positive, alpha-beta T cell | 5 studies | 24% ± 8% | |
| endothelial cell | 5 studies | 29% ± 7% | |
| epithelial cell | 5 studies | 36% ± 16% | |
| GABAergic neuron | 5 studies | 30% ± 12% | |
| astrocyte | 5 studies | 23% ± 8% | |
| natural killer cell | 4 studies | 27% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 20% ± 6% | |
| CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
| mature NK T cell | 4 studies | 21% ± 3% | |
| ciliated cell | 4 studies | 23% ± 7% | |
| lymphocyte | 4 studies | 25% ± 8% | |
| glutamatergic neuron | 4 studies | 39% ± 17% | |
| macrophage | 4 studies | 21% ± 5% | |
| interneuron | 4 studies | 31% ± 22% | |
| leukocyte | 3 studies | 16% ± 1% | |
| microglial cell | 3 studies | 22% ± 2% | |
| oligodendrocyte precursor cell | 3 studies | 26% ± 8% | |
| endothelial cell of lymphatic vessel | 3 studies | 18% ± 4% | |
| fibroblast | 3 studies | 19% ± 3% | |
| neuron | 3 studies | 24% ± 6% | |
| oligodendrocyte | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3631.16 | 1445 / 1445 | 100% | 35.12 | 183 / 183 |
| skin | 100% | 5291.88 | 1809 / 1809 | 100% | 28.81 | 472 / 472 |
| breast | 100% | 3627.87 | 459 / 459 | 100% | 27.74 | 1117 / 1118 |
| prostate | 100% | 3236.18 | 245 / 245 | 100% | 28.68 | 501 / 502 |
| intestine | 100% | 3968.21 | 966 / 966 | 99% | 25.84 | 524 / 527 |
| bladder | 100% | 3449.95 | 21 / 21 | 99% | 25.23 | 501 / 504 |
| lung | 100% | 3361.04 | 578 / 578 | 99% | 28.92 | 1148 / 1155 |
| stomach | 100% | 2732.25 | 359 / 359 | 99% | 26.74 | 284 / 286 |
| thymus | 100% | 3554.88 | 652 / 653 | 99% | 32.12 | 601 / 605 |
| uterus | 100% | 4469.92 | 170 / 170 | 99% | 28.02 | 453 / 459 |
| pancreas | 100% | 1958.34 | 327 / 328 | 99% | 24.99 | 176 / 178 |
| kidney | 100% | 2003.97 | 89 / 89 | 98% | 17.81 | 881 / 901 |
| brain | 98% | 2778.24 | 2579 / 2642 | 99% | 24.09 | 699 / 705 |
| ovary | 100% | 4637.44 | 180 / 180 | 96% | 16.15 | 413 / 430 |
| adrenal gland | 100% | 2449.20 | 258 / 258 | 94% | 17.79 | 216 / 230 |
| liver | 100% | 1689.58 | 226 / 226 | 84% | 11.19 | 343 / 406 |
| adipose | 100% | 3402.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2414.84 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3660.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 28.14 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 13.97 | 1 / 1 |
| blood vessel | 100% | 2873.57 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 27.38 | 79 / 80 |
| heart | 98% | 1646.87 | 844 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 18.21 | 28 / 29 |
| peripheral blood | 74% | 1442.00 | 685 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1903706 | Biological process | regulation of hemopoiesis |
| GO_0043249 | Biological process | erythrocyte maturation |
| GO_0051602 | Biological process | response to electrical stimulus |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0035902 | Biological process | response to immobilization stress |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
| GO_0050793 | Biological process | regulation of developmental process |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0043204 | Cellular component | perikaryon |
| GO_0030425 | Cellular component | dendrite |
| GO_0036409 | Cellular component | histone H3-K14 acetyltransferase complex |
| GO_0070776 | Cellular component | MOZ/MORF histone acetyltransferase complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0043997 | Molecular function | histone H4K12 acetyltransferase activity |
| GO_0036408 | Molecular function | histone H3K14 acetyltransferase activity |
| GO_0042393 | Molecular function | histone binding |
| GO_0043996 | Molecular function | histone H4K8 acetyltransferase activity |
| GO_0140566 | Molecular function | histone reader activity |
| GO_0043995 | Molecular function | histone H4K5 acetyltransferase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | BRD1 |
| Protein name | Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2) BRD1 protein Bromodomain containing 1 |
| Synonyms | BRPF2 BRL |
| Description | FUNCTION: Scaffold subunit of various histone acetyltransferase (HAT) complexes, such as the MOZ/MORF and HBO1 complexes, that acts as a regulator of hematopoiesis . Plays a key role in HBO1 complex by directing KAT7/HBO1 specificity towards histone H3 'Lys-14' acetylation (H3K14ac), thereby promoting erythroid differentiation . . |
| Accessions | ENST00000438393.5 ENST00000404034.5 [O95696-1] ENST00000404760.6 [O95696-2] J3KQ61 O95696 Q86X06 ENST00000457780.3 [O95696-2] ENST00000216267.12 [O95696-1] |